TuttoCongressi
E-mail
Password
 Resta Collegato

Cerca per parole nell'archivio:
In archivio:
  • N° Relazioni: 478
  • N° Accessi Relaz.: 168924
Web Video
Portale Giovani Medici

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali Live Demo

   Mostra tutti | Mostra contenuti EasyRec   
ABCDEFGHIJKLMNOPQRSTUVWXYZ
D
Dan Rujescu 
Daniel C. Javitt 
Effects of intranasal AL-108 (Davunetide) on neurocognition and functional outcome in schizopherenia
Daniel R. Weinberger 
Genetic regulation of GABA activity and risk for schizophrenia
Daniel Weinberger 
David A. Lewis 
Developmental refinements in synaptic markers of cortical GABA transmission
David Porteous 
DISC1 Pathway Expression in Mouse and Man
Deepak Cyril D'Souza 
Glycine Transporter Inhibition Attenuates the Psychotomimetic Effects of Ketamine in Healthy Human Subjects
Dieter Naber 
Quality of Life
Discusant - Til Wykes 
Discussant - Anthony Grace 
Discussant - Carol L. M. Caton 
Discussant - Carol Tamminga 
Discussant - Celso Arango 
Discussant - Christos Pantelis 
Discussant - David Lewis 
Discussant - Dennis Grayson 
Discussant - Elaine Walker 
Discussant - Inez Myin-Germeys 
Discussant - James Kennedy 
Discussant - joel Kleinman 
Discussant - John Kane 
Discussant - John Kane 
Discussant - Joseph Callicott 
Discussant - Kim T. Mueser 
Discussant - Lisa Dixon 
Discussant - Lynn DeLisi 
Discussant - Mary Cannon 
Discussant - Max Birchwood 
Discussant - Max Marshall 
Discussant - Nina Schooler 
Discussant - Paul Harrison 
Discussant - Richiard S. Keefe 
Discussant - Robin Murray 
Discussant - Shitij Kapur 
Discussant - Shitij Kapur 
Discussant - Shitij Kapur 
Discussant - Sophia Frangou 
Discussant - Til Wykes 
Discussant - Wolfgang Fleischhacker 
Discussant - Wolfgang Fleischhacker 
Discussant - Zerrin Atakan 
Donald C. Goff 
Searching for Cognitive Enhancers in Schizophrenia: The TURNS Program Strategy
Douglas L. Noordsy 
Are There Synergistic Interactions Between Antipsychotic Medications and Psychosocial Rehabilitation? Evidence From A Double-Blind Randomized Trial of Risperidone vs. Olanzapine Among Participants In Vocational Rehabilitation
 

   home   |   progetto   |   chi siamo   |   servizi   |   contatti   |   note legali
Tuttocongressi ©1995 - 2026 | Via Dei Perfetti Ricasoli, 94-96 - 50127 Firenze  |  P.Iva 03755090481